eXoZymes, Inc. (EXOZ)
4.30
+0.19
(+4.62%)
USD |
NASDAQ |
Nov 06, 10:22
eXoZymes EPS Diluted (Quarterly) : -0.3324 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3324 |
| March 31, 2026 | -0.2802 |
| December 31, 2025 | -0.3164 |
| September 30, 2025 | -0.2727 |
| June 30, 2025 | -0.2818 |
| March 31, 2025 | -0.2218 |
| Date | Value |
|---|---|
| December 31, 2024 | -0.2194 |
| September 30, 2024 | -0.2649 |
| June 30, 2024 | -0.1626 |
| December 31, 2023 | -0.1313 |
| December 31, 2022 | -0.0468 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 0.2412 |
| Perspective Therapeutics, Inc. | -0.222 |
| MiMedx Group, Inc. | -0.0595 |
| ABVC BioPharma, Inc. | -0.0283 |
| Endonovo Therapeutics, Inc. | -0.0003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.879M |
| Total Expenses (Quarterly) | 2.879M |
| Enterprise Value | 33.58M |
| Earnings Yield | -27.95% |
| Normalized Earnings Yield | -28.27 |